|
|
||||||||
Letters to the Editor |
,
Juergen Gieseke, PhD *
, and
Hans H. Schild, MD *
* Department of Radiology, University of Bonn, Sigmund Freud Str 25, Bonn 53105, Germany
Philips Medical Systems, Hamburg, Germany
e-mail: kuhl{at}uni-bonn.de
Editor:
In the June 2006 issue of Radiology, we reported on our results on dynamic contrast material–enhanced breast magnetic resonance (MR) imaging at 3.0 T, with 1.5 T comparison in the same patients (1). Our results suggest that the higher spatial resolution afforded by the higher magnetic field strength could be translated into a higher diagnostic confidence with which enhancing lesions were categorized. However, we would like to alert the radiologic community regarding an important pitfall that may be associated with breast MR imaging at 3.0 T. It seems that, due to spatial B1 inhomogeneities across the field of view, enhancement of lesions may be reduced to a variable degree. The loss of enhancement will be more important with two-dimensional (2D) than with three-dimensional (3D) gradient-echo protocols. Accordingly, and until more data are available, we recommend to only use 3D gradient-echo for breast MR imaging at 3.0 T. But even then, 3.0-T breast MR images must be interpreted with great care. Enhancement thresholds must not be used for differential diagnosis. B1 maps should be obtained in every patient in order to identify areas with reduced B1 and, thus, reduced enhancement.
In our article we already reported that, against our expectation, the enhancement rates of lesions at 3.0 T had been lower than the respective enhancement rates obtained for the same lesions at 1.5 T. We already mentioned in the discussion that one reason for this was probably the fact that in order to comply with specific absorption rate limitations at 3.0 T, the flip angle had to be reduced from 90° (at 1.5 T) down to 60°–73° (at 3.0 T).
Meanwhile, we further investigated the reason for the lower-than-expected enhancement at 3.0 T and performed a systematic analysis of the radiofrequency field (B1 field) obtained with the setup described in our article. We obtained B1 maps for bilateral breast MR imaging at 3.0 T with a four- and a seven-channel breast coil (Figure). Our results show that the B1 field across the field of view varies substantially, irrespective of the coil type. We observed consistently lower B1 fields in the area of the right breast compared with the left breast, with a left-to-right difference by a factor of around two. The regionally variable B1 fields will translate into regionally variable flip angles. Regionally variable flip angles will translate into a regionally variable T1-weighting and thus to variable enhancement of lesions, with reduced enhancement of lesions located in "low B1 areas" of the right breast.
|
The same will also apply for 3D gradient-echo protocols. However, due to the inherently higher baseline T1 contrast of 3D versus 2D imaging (which, in turn, is due to the substantially shorter repetition time of 3D protocols), the enhancement obtained even with lower flip angles will be consistently higher than that obtained with 2D protocols. Accordingly, nonenhancing breast cancers are not to be expected for 3D protocols at 3.0 T. However, diagnostic errors due to seemingly mild (ie, "benign") enhancement, are conceivable. This holds especially true because the predictable left-to-right differences in enhancement may be confusing.
It is important to note that the regionally variable flip angle may not be identifiable on the actual (non–fat-suppressed or fat-suppressed) gradient-echo images—that is, the pre- and postcontrast images will look fairly normal (Figure)—which means that a radiologist or a technologist will not realize that there is a B1 inhomogeneity.
Currently, we investigate whether the observed B1 inhomogeneities are caused by dielectric effects, and if so, which factors (patient size, patient position with respect to the body coil, breast size, breast composition) determine the B1 homogeneity in high-field-strength breast MR imaging.
| REFERENCE |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. E. Mountford, P. Stanwell, S. Ramadan, C. K. Kuhl, H. Kooijman, J. Gieseke, and H. H. Schild Breast MR Imaging at 3.0 T Radiology, July 1, 2008; 248(1): 319 - 320. [Full Text] [PDF] |
||||
![]() |
C. K. Kuhl, F. Traber, J. Gieseke, W. Drahanowsky, N. Morakkabati-Spitz, W. Willinek, M. von Falkenhausen, C. Manka, and H. H. Schild Whole-Body High-Field-Strength (3.0-T) MR Imaging in Clinical Practice * Part II. Technical Considerations and Clinical Applications Radiology, April 1, 2008; 247(1): 16 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Kuhl, F. Traber, and H. H. Schild Whole-Body High-Field-Strength (3.0-T) MR Imaging in Clinical Practice * Part I. Technical Considerations and Clinical Applications Radiology, March 1, 2008; 246(3): 675 - 696. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |